Xponance’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$201K Buy
7,001
+144
+2% +$4.14K ﹤0.01% 1330
2025
Q1
$230K Buy
6,857
+573
+9% +$19.2K ﹤0.01% 1218
2024
Q4
$321K Buy
6,284
+1,168
+23% +$59.7K ﹤0.01% 1105
2024
Q3
$261K Buy
5,116
+186
+4% +$9.51K ﹤0.01% 1131
2024
Q2
$221K Buy
+4,930
New +$221K ﹤0.01% 1150